BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Clinical Outcome
6 results:

  • 1. Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions.
    Hilmi M; Neuzillet C; Calderaro J; Lafdil F; Pawlotsky JM; Rousseau B
    J Immunother Cancer; 2019 Nov; 7(1):333. PubMed ID: 31783782
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis.
    Takano M; Shimada K; Fujii T; Morita K; Takeda M; Nakajima Y; Nonomura A; Konishi N; Obayashi C
    BMC Cancer; 2016 Nov; 16(1):903. PubMed ID: 27863477
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma.
    Aigelsreiter A; Ress AL; Bettermann K; Schauer S; Koller K; Eisner F; Kiesslich T; Stojakovic T; Samonigg H; Kornprat P; Lackner C; Haybaeck J; Pichler M
    Br J Cancer; 2013 May; 108(9):1830-7. PubMed ID: 23591196
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
    Li B; Liu W; Wang L; Li M; Wang J; Huang L; Huang P; Yuan Y
    Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Survival of patients with liver metastasis from colorectal cancer by different modes of therapy: a report of 363 cases].
    Xu JM; Qin XY; Zhong YS; Wei Y; Fan J; Zhou J; Qin LX; Wang JH; Yan ZP; Cheng JM; Wu ZH
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):54-7. PubMed ID: 17575696
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Genetic detection and clinical applications in patients with hepatocellular carcinoma].
    Takeda S; Nakao A
    Nihon Geka Gakkai Zasshi; 2002 Jun; 103(6):472-5. PubMed ID: 12094698
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.